Process development of telacebec for tuberculosis

Ended Awarded Last action

Contract number
75N95024F00002
Awardee
Awarding agency
Obligated
$1,042,565

Award facts

Opportunity
  • 75N95024R00096 Solicitation number
Contract value 95% obligated
  • $1,042,565.00 Current, with exercised options
  • $1,096,644.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Kansas City, MO 64110, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 $300,673
Exercise an Option P00001 · Exercise options 1,2,3,4 $136,605
Original award $605,287

About this award

The National Institute on Drug Abuse issued a delivery order to Mriglobal (doing business as Midwest Research Institute) on September 30, 2024, under the NCATS Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances parent contract for process development of telacebec for tuberculosis. The order carries a ceiling value of $1,096,644 and an ultimate completion date of September 29, 2026.

Place of performance is Kansas City, MO. The order is priced on a cost-plus-fixed-fee basis. Service Contract Inventory reporting shows actual FY2025 invoicing of $495 thousand across 0.9 FTEs, with the prime self-performing all reported hours and no subcontractors engaged.

Quick answers

Who was awarded contract 75N95024F00002?

75N95024F00002 was awarded to Mriglobal by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2024.

How much is contract 75N95024F00002 worth?

The government has obligated $1,042,565 on 75N95024F00002. Its potential value, with all options, is $1,096,644.

Is contract 75N95024F00002 an order under another contract?

Yes. 75N95024F00002 is a delivery order under 75N95024D00012, an indefinite delivery contract, on NCATS Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances.

Was contract 75N95024F00002 competed?

The extent of competition for 75N95024F00002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award